Hualan Biological Bacterin Inc.
Shenzhen Stock Exchange:301207.SZ
Sector
Industries
Location
Market Cap
USD 1.54 B
Share Price
USD 2.56
Avg Daily Volume
3,482,257
Change (1 day)
-0.25%
Change (1 year)
4.41%
Change (YTD)
6.77%
Hualan Biological Bacterin Inc. Operating Cash Flow for the year ending December 31, 2023: USD 125.08 M
Hualan Biological Bacterin Inc. Operating Cash Flow is USD 125.08 M for the year ending December 31, 2023, a 199.02% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Hualan Biological Bacterin Inc. Operating Cash Flow for the year ending December 31, 2022 was USD 41.83 M, a -53.32% change year over year.
-
Hualan Biological Bacterin Inc. Operating Cash Flow for the year ending December 31, 2021 was USD 89.60 M, a -15.69% change year over year.
-
Hualan Biological Bacterin Inc. Operating Cash Flow for the year ending December 31, 2020 was USD 106.28 M.
StockViz
Competitors
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 134.28
ABT
+2.22
1.68%
Novartis AG
USD 116.31
NOVN.SW
+1.16
1.00%
Merck & Co., Inc.
USD 80.69
MRK
+0.32
0.40%
Amgen Inc.
USD 288.23
AMGN
+3.53
1.24%
Pfizer Inc.
USD 24.58
PFE
+0.35
1.44%
Sanofi
USD 94.22
SAN.PA
-0.08
-0.08%
CSL Limited
USD 170.04
CSL.AX
-3.16
-1.82%
GSK plc
USD 18.80
GSK.L
-0.55
-2.85%
Zoetis Inc.
USD 147.35
ZTS
-0.89
-0.60%
Regeneron Pharmaceuticals, Inc.
USD 563.00
REGN
+3.20
0.57%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.49
600276.SS
+0.02
0.26%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 134.28
ABT
+2.22
1.68%
Novartis AG
USD 116.31
NOVN.SW
+1.16
1.00%
Merck & Co., Inc.
USD 80.69
MRK
+0.32
0.40%
Amgen Inc.
USD 288.23
AMGN
+3.53
1.24%
Pfizer Inc.
USD 24.58
PFE
+0.35
1.44%
Sanofi
USD 94.22
SAN.PA
-0.08
-0.08%
CSL Limited
USD 170.04
CSL.AX
-3.16
-1.82%
GSK plc
USD 18.80
GSK.L
-0.55
-2.85%
Zoetis Inc.
USD 147.35
ZTS
-0.89
-0.60%
Regeneron Pharmaceuticals, Inc.
USD 563.00
REGN
+3.20
0.57%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.49
600276.SS
+0.02
0.26%